Robert Ward has joined Greenberg Traurig as a shareholder with the firm’s life sciences and medical technology practice in San Diego, the firm said Tuesday.
Ward counsels technology companies and venture capital firms on intellectual property-related matters, with a focus on companies in the medical device and digital health industries, according to the firm.
He develops global patent portfolios for established and emerging companies, including many that utilize artificial intelligence and machine learning, and advises tech companies on IP licensing, development, consulting, and manufacturing agreements as well as acquisitions and spinouts, the firm said.
He joins from Eversheds Sutherland, ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.